Podcast Episodes
Back to SearchHow e-pharmacies are living but still on the edge
Episode 58
Ever since they came up a little less than a decade ago, e-pharmacies have been fighting a constant battle. On one hand there is the severe pushback …
2 years, 11 months ago
Google and Jio's cost-friendly phone ended up being a costly mistake
Episode 57
In 2020, Google invested $4.5 billion in Reliance's Jio Platforms for a 7.7% equity. The flagship product of this alliance was a budget friendly 4G …
3 years ago
Swiggy’s 1000 crore plan to save itself from the delivery partner crisis
Episode 56
The Blinkit delivery workers' strike that began last week has brought the spotlight back on the delivery personnel crisis in India. Just last year in…
3 years ago
Pandemic dealt a knockout punch to BookMyShow. Now it’s coming back with a new face
Episode 55
BookMyShow has its share of testing times since its birth back in 1998. The last one came as the pandemic and brought the platform down to its knees.…
3 years ago
Nykaa gambled on fashion. Was it worth the risk?
Episode 54
After its listing, investors were almost bullish about Nykaa shares. And for good reason. The company has been a pioneer in normalising buying beauty…
3 years ago
"Hello, I’m calling from Bajaj Finance. Do you want a loan?"
Episode 53
Phone calls from Bajaj Finance offering loans are almost inescapable and lately, the non-bank has been facing quite a backlash for it.
But telecalling…
3 years ago
Regulating 'finfluencers' is a slippery slope
Episode 52
According to a survey by S&P, more than 75 per cent of Indian adults do not understand basic financial concepts. The gap is more when it comes to wom…
3 years ago
How Disney+Hotstar is trying to fill the IPL-sized void
Episode 51
With the digital streaming rights to IPL gone and the recent losses it posted, India's undisputed OTT leader is trying to figure out a new strategy t…
3 years ago
India’s TB patients can finally celebrate the end of Johnson & Johnson’s monopoly disguised as charity
Episode 50
India’s patent office decided to reject pharma giant Johnson &Johnson’s appeal to extend the patent for a life-saving TB medicine called bedaquiline …
3 years ago
NPCI's latest directive could prove to be a game-changer for Paytm
Episode 49
If you had to compare all the online payment methods available to us, digital wallets like Paytm have gone through the roughest of waters. From bein…
3 years ago